Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...

Chilean foodtech firm NotCo says it expects to be profitable in Chile, Argentina, Colombia, and Peru in Q2, 2025.

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

People are buying healthier snacks and household food bills are dropping as GLP-1 weight-loss drugs alter eating habits Move ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

There are so many false promises online when it comes to losing weight. Here are my top weight loss technologies that ...

GLP-1s can deliver value to patients. But the fact that GLP-1s aren't cost-effective at their current net prices can limit ...